Immunization Roundup: Reducing Long COVID, Moderna Flu Vaccine, and More
Drug Topics
JULY 31, 2024
Catch up on important immunization news from the month of July.
Drug Topics
JULY 31, 2024
Catch up on important immunization news from the month of July.
PharmaVoice
JULY 31, 2024
The U.S. government will demand payment from Big Pharma to make up for dozens of drugs with prices that rose faster than the rate of inflation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 31, 2024
The investigational oral, selective NaV1.8 pain signal inhibitor from Vertex Pharmaceuticals demonstrated a favorable benefit/risk profile in 3 phase 3 trials.
STAT
JULY 31, 2024
Mount Sinai, a leading hospital network in New York City, has mounted an extraordinary behind-the-scenes campaign to blunt the fallout over revelations about its controversial research project in which brain biopsies are taken from patients undergoing deep brain stimulation, STAT has learned. That has included not only enlisting its own patients to defend the research but also seeking to stop a professional society of neurosurgeons from issuing a statement that could have jeopardized the researc
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 31, 2024
Anisha Patel, PharmD, a pharmacist turned podcast host, shares insights on leveraging all the opportunities pharmacy has to offer to build a diverse and rewarding career.
STAT
JULY 31, 2024
Untreated vision loss and high LDL cholesterol have been added as two new potentially modifiable risk factors for dementia in a report released Wednesday by the Lancet Commission. These new additions join 12 other risk factors outlined by the commission, affiliated with University College London, in previous reports on dementia prevention, intervention, and care in 2017 and 2020.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JULY 31, 2024
The findings indicate that zoster vaccine recombinant reduced dementia risk by 17% in an analysis of over 200,000 patients.
Drug Topics
JULY 31, 2024
Catch up on important diabetes news from the month of July.
STAT
JULY 31, 2024
CHICAGO — “Buttery Biscuits & Hot Honey Gravy,” mushroom jerky, soy chicken nuggets, strawberry champagne donuts, plant-based frozen yogurt and buñuelos, white cheddar cheese puffs, chocolatey cookie dippers, egg-free Spanish cheesecake, plant-based chorizo-style empanadas … I was at the annual gathering of food technologists this month to learn about, well, food technology, and I had found myself in the exhibit hall, testing how much I could eat before needi
Pharmacy Times
JULY 31, 2024
Pharmacies can adapt by embracing digital self-service options to better engage with patients, meet increasing consumer demand, and enhance revenue streams.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JULY 31, 2024
A trust controlled by 23andMe co-founder Anne Wojcicki has formally filed to take the genetic testing firm private, offering to purchase all shares of the firm for 40 cents per share, the current stock price. The deal, which Wojcicki had previously telegraphed, was made public in a filing with the Securities and Exchange Commission on Wednesday; the proposal was made to a special committee of 23andMe’s board on Monday.
Fierce Healthcare
JULY 31, 2024
Humana affirmed its guidance for the year as it continues to face headwinds in the Medicare Advantage (MA) space. | Humana affirmed its guidance for the year as it continues to face headwinds in the Medicare Advantage space.
STAT
JULY 31, 2024
The Biden administration isn’t doing enough to ensure people living in recovery housing have access to gold-standard addiction medications like methadone and buprenorphine , according to a coalition of health care, harm reduction, and addiction recovery groups. The discrimination that people often face when seeking treatment using methadone or buprenorphine, the groups say, is especially pronounced within recovery housing facilities, which typically offer lodging coupled with counse
Fierce Healthcare
JULY 31, 2024
In its first quarter with new CEO Chuck Divita, national telehealth provider Teladoc Health posted a net loss of $838 million in Q2 that included a nearly $800 million impairment charge a | Teladoc said on its earnings call on Wednesday that challenges with BetterHelp and increasing advertising costs led its revenue to decline in Q2.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JULY 31, 2024
The BIOSECURE Act , now rolling through Congress, aims to protect the DNA data of Americans from companies with perceived national security risks. That is a noble goal. But the legislation’s misguided approach would single out a small number of companies, including the California-based company I founded in 2005, Complete Genomics , despite the fact that we have no access to such data.
Fierce Healthcare
JULY 31, 2024
There are 75,000 homeless people in Los Angeles County, a county that is the size of Delaware and Rhode Island combined and has a population that is larger than 40 states. | L.A. Care Health Plan is sending social workers to temporary housing sites in Los Angeles County to find more permanent housing solutions.
Pharmacy Times
JULY 31, 2024
Patients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.
Fierce Healthcare
JULY 31, 2024
Wells Fargo is the most recent corporation to get sued, as alleged by former employees, for inadequately overseeing the price workers were forced to pay for prescription drug prices. | Wells Fargo was named as a defendant in a new lawsuit for not protecting its workers from extreme prescription drug prices inflicted by Cigna's PBM, Express Scripts.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JULY 31, 2024
In my third week as a medical intern, I learned a vital lesson about the realities of everyday medicine that textbooks and professors hadn’t taught me: how profoundly the financial cost of care affects patients. I was caring for a man admitted to the hospital with uncontrolled atrial fibrillation, an irregular and often rapid heartbeat. After much deliberation, I prescribed a new anticoagulant to prevent the formation of blood clots in his heart, instructed him to continue using his curre
pharmaphorum
JULY 31, 2024
Frontiers Health 2024 is a platform connecting innovators and changemakers in the life sciences industry to cultivate positive changes in health systems. Discover the latest trends and insights in healthcare innovation.
Fierce Healthcare
JULY 31, 2024
Bicycle Health, a virtual provider of opioid use disorder (OUD) treatment, is launching a program for teens in the state of Maine. | The company says this is the first program of its kind in the country. Patients 16 and 17 years of age will be eligible for medications for opioid use disorder via telehealth under the model. Bicycle decided to offer it in the state after hearing about a need directly from one of its payer partners.
pharmaphorum
JULY 31, 2024
Vertex has filed for FDA approval of its non-opioid pain drug suzetrigine, starting the clock ticking on a review that should be completed early next year
STAT
JULY 31, 2024
Good morning. We have a new investigation out today about how Mount Sinai in New York mounted an aggressive campaign to stifle debate over its controversial brain research. Check it out here. And let’s get into the biotech news.
pharmaphorum
JULY 31, 2024
Patient advocacy group APIC has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir
Fierce Pharma
JULY 31, 2024
Four months after Bayer handed pink slips to 90 staffers at its U.S. headquarters in Whippany, New Jersey, the company is laying off 70 more workers at the site. | Four months after Bayer handed pink slips to 90 staffers at its U.S. headquarters in Whippany, New Jersey, the company is laying off 70 more at the site, according to a state Worker Adjustment and Retraining Notification.
pharmaphorum
JULY 31, 2024
Ensuring equitable access to medications remains a fundamental commitment for many pharmaceutical companies to their customers, patients, and stakeholders. However, there has been a discernible shift recently in the timing of access discussions.
Pharmacy Times
JULY 31, 2024
If approved, the drug would be the first in a new class of medications to treat acute pain in over 20 years.
pharmaphorum
JULY 31, 2024
GSK raises 2024 forecasts on a strong Q2 led by HIV and cancer drugs, but its shares weakened on litigation concerns and weaker vaccine expectations
Pharmacy Times
JULY 31, 2024
The presence of glutamic acid decarboxylase antibodies in intravenous immunoglobulin can lead to a misdiagnosis of type 1 diabetes mellitus if a false-positive result is garnered.
STAT
JULY 31, 2024
Good morning, folks! The Dean of Pharmalittle University, Ed Silverman, is out on vacation. I also recently went on a mini-vacation, traveling up to a lake house for fun with friends. I’ll be writing my “What I did on summer vacation” essay later this week. But first, the news. … A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimer’s disease, supporting the case for further research on this class of medication
Pharmacy Times
JULY 31, 2024
The study also found that there were no associations with increased dementia risk when anxiety resolved.
STAT
JULY 31, 2024
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Surprisingly, a story by my colleagues Nick Florko and Sarah Owermohle about how Grindr hired a Washington lobbyist is NOT the first time the, uh, “social networking app” (their words!) has appeared in STAT reporting. A quick Google search tells me that the word first appeared in an early episode of The Readout LOUD.
Pharmaceutical Commerce
JULY 31, 2024
The latest news for pharma industry insiders.
Let's personalize your content